AT243987B - Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe, Hepatitis contagiosa canis und Leptospirose - Google Patents
Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe, Hepatitis contagiosa canis und LeptospiroseInfo
- Publication number
- AT243987B AT243987B AT553063A AT553063A AT243987B AT 243987 B AT243987 B AT 243987B AT 553063 A AT553063 A AT 553063A AT 553063 A AT553063 A AT 553063A AT 243987 B AT243987 B AT 243987B
- Authority
- AT
- Austria
- Prior art keywords
- leptospirosis
- vaccine
- dogs
- production
- simultaneous immunization
- Prior art date
Links
- 241000282421 Canidae Species 0.000 title 1
- 241000282472 Canis lupus familiaris Species 0.000 title 1
- 208000000655 Distemper Diseases 0.000 title 1
- 206010024238 Leptospirosis Diseases 0.000 title 1
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB68006A DE1283438B (de) | 1962-07-12 | 1962-07-12 | Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Fuechsen gegen Staupe, Hepatitis contagiosa canis und Leptospirose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT243987B true AT243987B (de) | 1965-12-10 |
Family
ID=6975728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT553063A AT243987B (de) | 1962-07-12 | 1963-07-10 | Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Füchsen gegen Staupe, Hepatitis contagiosa canis und Leptospirose |
Country Status (8)
| Country | Link |
|---|---|
| AT (1) | AT243987B (OSRAM) |
| CA (1) | CA937864A (OSRAM) |
| DE (1) | DE1283438B (OSRAM) |
| FI (1) | FI40561B (OSRAM) |
| GB (1) | GB1008078A (OSRAM) |
| LU (1) | LU43999A1 (OSRAM) |
| NL (2) | NL145902B (OSRAM) |
| SE (1) | SE308574B (OSRAM) |
-
0
- NL NL295135D patent/NL295135A/xx unknown
-
1962
- 1962-07-12 DE DEB68006A patent/DE1283438B/de active Pending
-
1963
- 1963-07-03 LU LU43999D patent/LU43999A1/xx unknown
- 1963-07-10 AT AT553063A patent/AT243987B/de active
- 1963-07-10 NL NL295135A patent/NL145902B/xx not_active IP Right Cessation
- 1963-07-11 GB GB2760463A patent/GB1008078A/en not_active Expired
- 1963-07-11 FI FI137763A patent/FI40561B/fi active
- 1963-07-11 SE SE773363A patent/SE308574B/xx unknown
- 1963-07-11 CA CA879884A patent/CA937864A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| LU43999A1 (OSRAM) | 1963-09-03 |
| FI40561B (OSRAM) | 1968-11-30 |
| GB1008078A (en) | 1965-10-27 |
| CA937864A (en) | 1973-12-04 |
| NL145902B (nl) | 1975-05-15 |
| SE308574B (OSRAM) | 1969-02-17 |
| DE1283438B (de) | 1968-11-21 |
| NL295135A (OSRAM) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH439747A (de) | Verfahren zur Herstellung von Fluor enthaltenden Polymerisaten | |
| CH441286A (de) | Verfahren zur Herstellung von Alkenderivaten | |
| CH439290A (de) | Verfahren zur Herstellung von 4-Amino-6,7-dialkoxychinolinen | |
| CH456549A (de) | Verfahren zur Herstellung eines Katalysators | |
| AT240362B (de) | Verfahren zur Herstellung von Carbonsäureamiden | |
| CH433223A (de) | Verfahren zur Herstellung von Mannit und Sorbit | |
| AT242294B (de) | Verfahren zur Herstellung von Masernvaccin | |
| CH469093A (de) | Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenia | |
| CH457385A (de) | Verfahren zur Herstellung von Persäuren | |
| CH455768A (de) | Verfahren zur Herstellung von Pyridinen | |
| CH439749A (de) | Verfahren zur Herstellung von wässrigem Copolymer-Latex | |
| CH437352A (de) | Verfahren zur Herstellung von Aminophenolen | |
| CH394215A (de) | Verfahren zur Herstellung von Aminoketonderivaten | |
| AT336779B (de) | Verfahren zur herstellung einer intravenos vertraglichen vaccine gegen staupe und hepatitis contagiosa canis | |
| CH444136A (de) | Verfahren zur Herstellung von Dicarbonsäuredialkylestern | |
| AT243794B (de) | Verfahren zur Herstellung von Carbostyrilderivaten | |
| AT279038B (de) | Verfahren zur Herstellung eines Impfstoffes gegen Röteln | |
| AT238702B (de) | Verfahren zur Herstellung von 1-Acetoxy-1,1-dicyanoäthan | |
| CH460036A (de) | Verfahren zur Herstellung von Morphinan-Derivaten | |
| CH375339A (de) | Verfahren zur Herstellung von Benzolsulfonylharnstoffen | |
| CH441358A (de) | Verfahren zur Herstellung von Isoxazolen | |
| CH394203A (de) | Verfahren zur Herstellung von 1-R-2,5-Bis-halogenmethylpyrrolidinen sowie deren Salzen | |
| AT248427B (de) | Verfahren zur Herstellung von 3-Amino-2-oxazolidon-hydrochlorid | |
| CH416653A (de) | Verfahren zur Herstellung von 2-Methyl-3-o-äthylphenyl-4-oxo-3,4-dihydro-chinazolin | |
| CH439282A (de) | Verfahren zur Herstellung von 11-Keto-5a,9B,10a-19-nor-steroiden |